Evidence mapPaperPMID 40717809Full record

SynthesisFrontiers in endocrinology2025

Risk prediction models for diabetic retinopathy: a systematic review.

Hui Huang, Yingmin Wu, Hejiang Ye, Jiaoyang Li, Ling Chen, Xuan Huang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui HuangSchool of Management, Chengdu University of Traditional Chinese Medicine, Wenjiang, Chengdu, Sichuan, China.
Yingmin WuSchool of Management, Chengdu University of Traditional Chinese Medicine, Wenjiang, Chengdu, Sichuan, China.
Hejiang YeDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, Jinniu, Chengdu, Sichuan, China.
Jiaoyang LiSchool of Management, Chengdu University of Traditional Chinese Medicine, Wenjiang, Chengdu, Sichuan, China.
Ling ChenSchool of Management, Chengdu University of Traditional Chinese Medicine, Wenjiang, Chengdu, Sichuan, China.
Xuan HuangSchool of Management, Chengdu University of Traditional Chinese Medicine, Wenjiang, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetic retinopathy, a prevalent complication of Objective: To systematically evaluate published prediction models for diabetic retinopathy, select better prediction models for healthcare professionals, and provide a valuable reference for model optimization. Methods: A comprehensive search was conducted across the PubMed, Web of Science, Embase, and the Cochrane Library databases for relevant literature on predictive models for diabetic retinopathy. The search period was set from the time of library construction to November 14, 2023. Furthermore, risk of bias and applicability assessment of the included study models were performed using the PROBAST risk assessment tool. Results: A total of 2030 studies were retrieved, including 15 studies. The range of the working characteristic curve of the subjects for the 15 models varied from 0.700 to 0.960. All 15 included studies were recognized as high risk of bias. However, five studies had better applicability. The 15 models had Common risk factors for the 15 models included diabetes duration, age, glycosylated hemoglobin, serum creatinine and urinary albumin creatinine ratio. Conclusions: While the performance of the 15 models had certain predictive performance, the high risk of bias is a concern. Hopefully, future studies will ensure transparency and science in the model-building process by conducting large-sample integrated machine learning, reinforcing multicenter external validation. This study was registered with PROSPERO, an international prospective systematic evaluation registry platform, and the title was approved with registration number CRD42023483749. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024559392.

Indexed as

Diabetic RetinopathyHumansRisk AssessmentRisk Factorsdiabetesdiabetic retinopathy (DR)predictive modelingrisk factorssystematic review

Identifiers

PMID40717809
PMCPMC12291684

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.